With over 150 vaccine efforts underway as of July 2020 and nearly a half-dozen already in Phase III of clinical trials, the race for a coronavirus vaccine remains vigilant around the globe.
Follow the latest in vaccine development through the New York Times' live tracker.
With regard to treatments that might mitigate the effects of COVID-19 for individuals already infected with the virus, drug development efforts are similarly vital and ongoing. Those efforts can be tracked as well through the New York Times, which is updates its website regularly.
For readers interested in taking a deeper dive into the complexity that surrounds vaccine development, clinical trials and their different stages, and/or the ethical considerations inherent in this type of research, check out Episode 38 of the Useful Science podcast, hosted below.